BNB Plus Corp. (BNBX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Jul 10Jul 15Jul 20Jul 23Jul 28Jul 31Aug 5Aug 10

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.0x

Market Cap

$923797.45

MomentumView details →

1D Return

+0.00%

YTD Return

−88.62%

RSI (14)

41.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

0.0x

Market Cap

$923797.45

RSI (14)

41.7

MomentumView details →

1D Return

+0.00%

YTD Return

−88.62%

ProfitabilityView details →

Gross Margin

43.49%

Net Margin

−1646.94%

EBITDA Margin

−1657.56%

ROE (TTM)

−275.69%

ROA (TTM)

−252.85%

Asset Turnover

0.12x

GrowthView details →

Revenue YoY

−39.60%

EPS YoY

—

FCF YoY

+1.08%

Revenue CAGR 3Y

−51.00%

EPS CAGR 3Y

−96.67%

EBITDA YoY

—

EarningsView details →

EPS (Actual)

−$0.68

EPS Surprise

—

Beats (12Q)

7/12

Next Q EPS Est

—

Avg Surprise (4Q)

104.17%

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

1.82x

Quick Ratio

1.74x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

Financials snapshotView financials →

Revenue (TTM)

2.09M

Net Income (TTM)

−34.48M

Op. CF (TTM)

−13.79M

Latest newsMore news →

Robert B. Catell, Joseph D. Ceccoli and Dr. Yacov Shamash resigned as directors of BNB Plus Corp., effective September 3, 2026, and were succeeded by Richard Shorten, Todd Larsen and Lok Lee respectively.22h ago

BNB Plus agreed to pay $1 million in cash and issue 200,000 preferred shares to Cypress LLC and Cypress Management LLC to settle and terminate their digital-asset management and strategic-adviser agreements, following Nasdaq's suspension of BNBX stock.36d ago

Similar companies

Nexera Technologies LtdNEXR NKGen Biotech, Inc. WarrantsNKGNW Biodexa Pharmaceuticals PlcBDRX IO Biotech, Inc.IOBT Hepion Pharmaceuticals, Inc.HEPA YD Bio Limited WarrantsYDESW Find similar companies →

Latest newsMore news →

Robert B. Catell, Joseph D. Ceccoli and Dr. Yacov Shamash resigned as directors of BNB Plus Corp., effective September 3, 2026, and were succeeded by Richard Shorten, Todd Larsen and Lok Lee respectively.22h ago BNB Plus agreed to pay $1 million in cash and issue 200,000 preferred shares to Cypress LLC and Cypress Management LLC to settle and terminate their digital-asset management and strategic-adviser agreements, following Nasdaq's suspension of BNBX stock.36d ago